GlassScriptPhysician profile
Christina Cervieri
NPI 1164427423
$15,898.58
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $3,924 · 2021: $3,352 · 2022: $1,684 · 2023: $2,192 · 2024: $3,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,583 · Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,582.61 |
| Food and Beverage | $1,272.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,342.07 | 2020-2024 | Distal Extremities Implants Foot & Ankle Ttc Nail |
| Supreme Orthopedic Systems, LLC | $5,039.13 | 2020-2024 | |
| Stryker Corporation | $2,772.90 | 2019-2024 | Iconix, Salvation, Inspace |
| Depuy Synthes Sales INC. | $1,159.07 | 2019-2024 | |
| Sawtooth Surgical Solutions INC | $896.00 | 2024 | |
| Abbott Laboratories | $314.26 | 2019 | |
| Smith+Nephew, INC. | $180.83 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $77.46 | 2019-2023 | Durolane |
| Fidia Pharma USA INC. | $46.80 | 2019 | |
| Medical Device Business Services, INC. | $38.27 | 2024 | Velys |
| Ferring Pharmaceuticals INC. | $19.20 | 2019 | |
| Zyla Life Sciences, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Cervieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.